Tagged with SME

Turkey Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare system could benefit from critical products which are not often considered to have strong ties to preventative care.   Can…

Poland Ewa Sek, general manager at ResMed Poland, explains the crucial role of ResMed in raising awareness on sleep apnea, COPD and other respiratory-related conditions in Poland and highlights the important investments that should be made to increase the diagnostics capabilities as well as to reimburse telemedicine and device accessories.  ResMed…

UK Tony Jones, CEO of One Nucleus, a life sciences membership organization centered on the Greater London-Cambridge-East of England corridor, discusses the role of SMEs within the UK’s healthcare ecosystem, translational research, and how the association’s members will navigate the post-Brexit landscape in the UK.  One Nucleus, which was established in…

Poland Philippe Coudiere, general manager of Pierre Fabre Dermo-cosmetics Poland, highlights the key partnerships the company has nurtured with pharmacists and dermatologists and the importance of clinical data for their products. Furthermore, he explains the need to develop a strong connection with end consumers and the dynamics of the Polish dermo-cosmetic…

UK Sarah Haywood, CEO of MedCity, the life science cluster for London, Oxford and Cambridge in the southeast of England, discusses the organization’s strategy, key achievements, Brexit, and supporting SMEs. Why was there a need to create yet another life sciences cluster four years ago? Aren’t there already enough in this…

Lithuania Daina Klepone, managing director at Enterprise Lithuania, explains the opportunities Lithuania can offer to healthcare businesses and how their organization can help them enter the market. Moreover, she introduces the ‘Life Sciences Baltics’ event, and its key role to promote the industry in the Baltic region. Could you please start…

Brazil Luis Fernando Lenski, head of South Cone and general manager of Galderma Brazil, provides insights into the affiliate’s heightened and tireless efforts in terms of medical education and his focus on improving the organization’s efficiency. Brazil is a Top Three market within Galderma’s global operations and holds a myriad of…

Switzerland Jean-François Gouzer, CEO of Scientis Pharma, discusses the company’s origin story, its specialization in skin pigmentation disorders, and future internationalization prospects Could you start by introducing the Scientis Pharma story and how the company was founded? “Switzerland is a great environment to do business and to create and develop a…

Brazil Alex Carvalho, general manager Pierre Fabre Brazil, provides insights into the rapidly ascending trajectory of the company in Brazil, its utmost commitment to oncology in the country, and Pierre Fabre’s eagerness to further investing in this strategic market. He also calls for a greater collaboration between all stakeholders to tackle…

Switzerland Petra Doerr, head of sector communication & networking as well as deputy executive director of Swissmedic, the Swiss surveillance authority for medicines and medical devices, discusses changes to the Swiss regulatory system and harmonizing the organization with its global counterparts. Swissmedic has embarked upon a comprehensive overhaul of its regulations in response…

Canada Linda Tibbits, general manager at Pierre Fabre Dermo-Cosmetics in Canada takes us back to the beginnings of the French company in the country, where its initial success was driven by the harmonic relationship between Pierre Fabre himself and Jean Coutu, founder of Canada’s largest pharmacy network. She further talks portfolio…

Tunisia Riadh Daghfous, managing director of the Tunisian National Pharmacovigilance Center (CNPV), describes the role of the CNPV in side-effect monitoring, pharmacovigilance, and marketing authorizations. CNPV plays a central role in Tunisia’s health system. Could you explain the CNPV’s main operating features, its means and attributions, as well as its interactions…